1. Home
  2. PODD vs NOK Comparison

PODD vs NOK Comparison

Compare PODD & NOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • NOK
  • Stock Information
  • Founded
  • PODD 2000
  • NOK 1865
  • Country
  • PODD United States
  • NOK Finland
  • Employees
  • PODD N/A
  • NOK N/A
  • Industry
  • PODD Medical/Dental Instruments
  • NOK Radio And Television Broadcasting And Communications Equipment
  • Sector
  • PODD Health Care
  • NOK Technology
  • Exchange
  • PODD Nasdaq
  • NOK Nasdaq
  • Market Cap
  • PODD 22.1B
  • NOK 23.1B
  • IPO Year
  • PODD 2007
  • NOK N/A
  • Fundamental
  • Price
  • PODD $324.61
  • NOK $6.91
  • Analyst Decision
  • PODD Strong Buy
  • NOK Strong Buy
  • Analyst Count
  • PODD 19
  • NOK 3
  • Target Price
  • PODD $346.95
  • NOK $7.05
  • AVG Volume (30 Days)
  • PODD 527.8K
  • NOK 77.2M
  • Earning Date
  • PODD 11-06-2025
  • NOK 10-23-2025
  • Dividend Yield
  • PODD N/A
  • NOK 1.52%
  • EPS Growth
  • PODD N/A
  • NOK 129.18
  • EPS
  • PODD 3.45
  • NOK 0.20
  • Revenue
  • PODD $2,521,800,000.00
  • NOK $23,170,245,221.00
  • Revenue This Year
  • PODD $29.32
  • NOK $6.23
  • Revenue Next Year
  • PODD $18.37
  • NOK $3.74
  • P/E Ratio
  • PODD $94.04
  • NOK $34.17
  • Revenue Growth
  • PODD 27.11
  • NOK 5.88
  • 52 Week Low
  • PODD $230.05
  • NOK $3.91
  • 52 Week High
  • PODD $353.50
  • NOK $8.19
  • Technical
  • Relative Strength Index (RSI)
  • PODD 54.24
  • NOK 63.04
  • Support Level
  • PODD $311.51
  • NOK $6.77
  • Resistance Level
  • PODD $335.00
  • NOK $7.18
  • Average True Range (ATR)
  • PODD 10.85
  • NOK 0.32
  • MACD
  • PODD 0.52
  • NOK -0.04
  • Stochastic Oscillator
  • PODD 76.85
  • NOK 45.86

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About NOK Nokia Corporation Sponsored

Nokia provides telecom equipment and services that are used to build wireless and fixed-line networks. It operates in four segments. The mobile networks segment, which sells equipment and services to telecom carriers to power public wireless networks, is the largest. Network infrastructure focuses on fixed networks, including infrastructure, solutions, and components for IP networks, optical networks, and submarine networks. Cloud and network services is a nascent segment catering to enterprises, offering as-a-service platforms. Nokia also has a sizable research division and patent business, where it licenses technology used by handset providers, consumer electronics firms, and other firms making electronic and Internet of Things products.

Share on Social Networks: